Lichen Simplex Chronicus Itch: An Update
DOI:
https://doi.org/10.2340/actadv.v102.4367Keywords:
itch, lichen simplex chronicus, physiopathology, pruritusAbstract
Lichen simplex chronicus is a form of chronic localized pruritus with a secondary dermatitis, and one of the most common types of chronic itch conditions, estimated to affect more than 10% of the general population. However, despite its prevalence and burden, there has been limited research into the pathogenesis and aetiology of lichen simplex chronicus, which, historically, made it a challenging condition to treat. In recent years, our understanding of this condition, along with that of pruritus and the itch-scratch cycle, has increased greatly, enabling a substantial increase in treatment options. In addition, there are several new promising treatments currently in development and trials. This article discusses the definition, epidemiology, clinical characteristics, pathophysiology, and current therapeutic options for lichen simplex chronicus, in order to highlight recent advancements in this field.
Downloads
References
Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus. N Engl J Med 2013; 368: 1625-1634.
https://doi.org/10.1056/NEJMcp1208814 DOI: https://doi.org/10.1056/NEJMcp1208814
Tianco EA, Buendia-Teodosio G, Alberto NL. Survey of skin lesions in the Filipino elderly. Int J Dermatol 1992; 31: 196-198.
https://doi.org/10.1111/j.1365-4362.1992.tb03935.x DOI: https://doi.org/10.1111/j.1365-4362.1992.tb03935.x
Mack MR, Kim BS. The itch-scratch cycle: a neuroimmune perspective. Trends Immunol 2018; 39: 980-991.
https://doi.org/10.1016/j.it.2018.10.001 DOI: https://doi.org/10.1016/j.it.2018.10.001
Charifa A, Badri T, Harris BW. Lichen simplex chronicus. Treasure Island (FL): StatPearls Publishing; 2022.
Crone AM, Stewart EJ, Wojnarowska F, Powell SM. Aetiological factors in vulvar dermatitis. J Eur Acad Dermatol Venereol 2000; 14: 181-186.
https://doi.org/10.1046/j.1468-3083.2000.00080.x DOI: https://doi.org/10.1046/j.1468-3083.2000.00080.x
Leow Y-H, Yosipovitch G. Pruritus in lichen simplex chronicus and lichen amyloidosis. Basic Clin Dermatol 2004; 27: 255-258.
Golpanian RS, Fourzali K, Fowler E, Kursewicz CD, Lipman Z, Chan YH, et al. The pleasurability of scratching an itch amongst different pruritic conditions. Acta Derm Venereol 2020; 100: adv00254.
https://doi.org/10.2340/00015555-3605 DOI: https://doi.org/10.2340/00015555-3605
Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1. J Allergy Clin Immunol 2014; 133: 448-460.
https://doi.org/10.1016/j.jaci.2013.10.048 DOI: https://doi.org/10.1016/j.jaci.2013.10.048
Qiu Y, Tang N, Zhang W, Xiong JX, Hu L, Cai T. Down-regulated expression of transient receptor potential ankyrin 1 in lichen simplex chronicus. Ann Palliat Med 2020; 9: 3757-3765.
https://doi.org/10.21037/apm-20-1712 DOI: https://doi.org/10.21037/apm-20-1712
Zhao J, Munanairi A, Liu XY, Zhang J, Hu L, Hu M, et al. PAR2 mediates itch via TRPV3 signaling in keratinocytes. J Invest Dermatol 2020; 140: 1524-1532.
https://doi.org/10.1016/j.jid.2020.01.012 DOI: https://doi.org/10.1016/j.jid.2020.01.012
Wilson SR, Thé L, Batia LM, Beattie K, Katibah GE, McClain SP, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 2013; 155: 285-295.
https://doi.org/10.1016/j.cell.2013.08.057 DOI: https://doi.org/10.1016/j.cell.2013.08.057
Cui S, Xiao T, Wang Y, Lu H, Wang Y, Gao XH, et al. Morphological relationship between nerve fibers and Langerhans cells in the epidermis of psoriasis vulgaris and lichen simplex chronicus. J Dermatol Sci 2009; 56: 132-134.
https://doi.org/10.1016/j.jdermsci.2009.07.009 DOI: https://doi.org/10.1016/j.jdermsci.2009.07.009
Sorour NE, Elesawy FM, Tabl HA, Ibrahim ME, Akl EM. Evaluation of serum levels of neurotrophin 4 and brain-derived nerve growth factor in uremic pruritus patients. Clin Cosmet Investig Dermatol 2019; 12: 109-114.
https://doi.org/10.2147/CCID.S190917 DOI: https://doi.org/10.2147/CCID.S190917
Altunay İ K, Özkur E, Uğurer E, Baltan E, Aydın Ç, Serin E. More than a skin disease: stress, depression, anxiety levels, and serum neurotrophins in lichen simplex chronicus. An Bras Dermatol 2021; 96: 700-705.
https://doi.org/10.1016/j.abd.2021.04.011 DOI: https://doi.org/10.1016/j.abd.2021.04.011
Sandoval M, Parra J, Reyna-Jeldes M, Curi-Tuma M, Espinoza F, Muñoz D, et al. Itch in lichen simplex chronicus is associated with localized small fiber neuropathy. J Invest Dermatol 2022; 142: 731-735.e3.
https://doi.org/10.1016/j.jid.2021.08.429 DOI: https://doi.org/10.1016/j.jid.2021.08.429
Yosipovitch G, Misery L, Proksch E, Metz M, Ständer S, Schmelz M. Skin barrier damage and itch: review of mechanisms, topical management and future directions. Acta Derm Venereol 2019; 99: 1201-1209.
https://doi.org/10.2340/00015555-3296 DOI: https://doi.org/10.2340/00015555-3296
Burgin S. Chapter 15. Nummular eczema, lichen simplex chronicus, and prurigo nodularis. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine, 8th edn. New York, NY: The McGraw-Hill Companies; 2012.
Goldstein AT, Thaçi D, Luger T. Topical calcineurin inhibitors for the treatment of vulvar dermatoses. Eur J Obstet Gynecol Reprod Biol 2009; 146: 22-29.
https://doi.org/10.1016/j.ejogrb.2009.05.026 DOI: https://doi.org/10.1016/j.ejogrb.2009.05.026
Remitz A, Harper J, Rustin M, Goldschmidt WF, Palatsi R, van der Valk PG, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Acta Derm Venereol 2007; 87: 54-61.
https://doi.org/10.2340/00015555-0167 DOI: https://doi.org/10.2340/00015555-0167
Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I. Treatment of skin disease e-book: comprehensive therapeutic strategies. Elsevier Health Sciences, Amsterdam; 2013.
Greaves MW. Recent advances in pathophysiology and current management of itch. Ann Acad Med Singap 2007; 36: 788-792.
Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol 1995; 131: 1403-1408. DOI: https://doi.org/10.1001/archderm.131.12.1403
https://doi.org/10.1001/archderm.1995.01690240065010 DOI: https://doi.org/10.1001/archderm.1995.01690240065010
Yosipovitch G, Sugeng MW, Chan YH, Goon A, Ngim S, Goh CL. The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol 2001; 45: 910-913.
https://doi.org/10.1067/mjd.2001.117399 DOI: https://doi.org/10.1067/mjd.2001.117399
Lee HG, Grossman SK, Valdes-Rodriguez R, Berenato F, Korbutov J, Chan YH, et al. Topical ketamine-amitriptyline-lidocaine for chronic pruritus: a retrospective study assessing efficacy and tolerability. J Am Acad Dermatol 2017; 76: 760-761.
https://doi.org/10.1016/j.jaad.2016.10.030 DOI: https://doi.org/10.1016/j.jaad.2016.10.030
Nattkemper LA, Zhi K, Romero KE, Shah SM, Ju T, Fourzali K, et al. Antipruritic effect of topical acetaminophen gel in histaminergic and non-histaminergic itch provocation: a double-blind, vehicle-controlled pilot study. Acta Derm Venereol 2022; 102: adv00640.
https://doi.org/10.2340/00015555-3910 DOI: https://doi.org/10.2340/00015555-3910
Ju T, Labib A, Vander Does A, Yosipovitch G. Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: a case series. J Am Acad Dermatol 2022; 87: 400-403.
https://doi.org/10.1016/j.jaad.2022.03.012 DOI: https://doi.org/10.1016/j.jaad.2022.03.012
Gencoglan G, Inanir I, Gunduz K. Therapeutic hotline: treatment of prurigo nodularis and lichen simplex chronicus with gabapentin. Dermatol Ther 2010; 23: 194-198.
https://doi.org/10.1111/j.1529-8019.2010.01314.x DOI: https://doi.org/10.1111/j.1529-8019.2010.01314.x
More on mu-opioid receptor antagonists in PD-1 blockade-induced pruritus. N Engl J Med 2019; 380: 601-602.
https://doi.org/10.1056/NEJMc1815143 DOI: https://doi.org/10.1056/NEJMc1815143
Lynch PJ. Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region. Dermatol Ther 2004; 17: 8-19.
https://doi.org/10.1111/j.1396-0296.2004.04002.x DOI: https://doi.org/10.1111/j.1396-0296.2004.04002.x
Hundley JL, Yosipovitch G. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. J Am Acad Dermatol 2004; 50: 889-891.
https://doi.org/10.1016/j.jaad.2004.01.045 DOI: https://doi.org/10.1016/j.jaad.2004.01.045
Sanjana V, Fernandez R. Evaluation of an antihistamine and an antidepressant for the treatment of lichen simplex chronicus. Ind J Dermatol Venereol Leprol 1992; 58: 384-387.
Qureshi AA, Abate LE, Yosipovitch G, Friedman AJ. A systematic review of evidence-based treatments for prurigo nodularis. J Am Acad Dermatol 2019; 80: 756-764.
https://doi.org/10.1016/j.jaad.2018.09.020 DOI: https://doi.org/10.1016/j.jaad.2018.09.020
Juarez MC, Kwatra SG. A systematic review of evidence based treatments for lichen simplex chronicus. J Dermatolog Treat 2021; 32: 684-692.
https://doi.org/10.1080/09546634.2019.1708856 DOI: https://doi.org/10.1080/09546634.2019.1708856
Esen Salman K, Kıvanç Altunay İ, Salman A. The efficacy and safety of targeted narrowband UVB therapy: a retrospective cohort study. Turk J Med Sci 2019; 49: 595-603.
https://doi.org/10.3906/sag-1810-110 DOI: https://doi.org/10.3906/sag-1810-110
Engin B, Tufekci O, Yazici A, Ozdemir M. The effect of transcutaneous electrical nerve stimulation in the treatment of lichen simplex: a prospective study. Clin Exp Dermatol 2009; 34: 324-328.
https://doi.org/10.1111/j.1365-2230.2008.03086.x DOI: https://doi.org/10.1111/j.1365-2230.2008.03086.x
Wu C, Zou M, Xiong Y, Wang L, Chen H, Fan Y, et al. Short- and long-term efficacy of focused ultrasound therapy for non-neoplastic epithelial disorders of the vulva. BJOG 2017; 124: 87-92.
https://doi.org/10.1111/1471-0528.14747 DOI: https://doi.org/10.1111/1471-0528.14747
Ständer S, Yosipovitch G, Legat FJ, Lacour JP, Paul C, Narbutt J, et al. Trial of nemolizumab in moderate-to-severe prurigo nodularis. N Engl J Med 2020; 382: 706-716.
https://doi.org/10.1056/NEJMoa1908316 DOI: https://doi.org/10.1056/NEJMoa1908316
Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME). ClinicalTrials.gov identifier: NCT 04183335. Updated February 17, 2022. [Accessed April 3, 2022] Available from https://clinicaltrials.gov/ct2/show/NCT04183335.
A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases. ClinicalTrials.gov identifier: NCT03858634. Updated December 28, 2021. [Accessed April 3, 2022] Available from https://ClinicalTrials.gov/show/NCT03858634.
Kamari Pharma L, Bioskin Gmb H. KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC). ClinicalTrials.gov identifier: NCT05454462. Updated July 12, 2022. [Accessed July 13, 2022] Available from https://clinicaltrials.gov/ct2/show/NCT05454462.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Teresa Ju, Ashley Vander Does, Noreen Mohsin, Gil Yosipovitch
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
